Quantifying the Clinical Significance of Cannabis Withdrawal

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Allsop, David J ^a   Copeland, Jan ^a   Norberg, Melissa M ^a   Fu, Shanlin ^b   Molnar, Anna ^b   Lewis, John ^b   Budney, Alan J ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANNABIS ADDICTION; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DETOXIFICATION; DISEASE SEVERITY; DSM-IV; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; QUANTITATIVE STUDY; SAMPLE SIZE;

ADOLESCENT; ADULT; CANNABIS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; RECURRENCE; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; SUBSTANCE WITHDRAWAL SYNDROME;

CANNABIS;

EID: 84866866000     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044864     Document Type: Article

References (48)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (Text Revision). Washington, DC: American Psychiatric Association.
2. Budney AJ, Hughes JR, (2006) The cannabis withdrawal syndrome. Current Opinion in Psychiatry 19: 233-238.
3. Haney M, (2005) The marijuana withdrawal syndrome: diagnosis and treatment. Current Psychiatry Reports 7: 360-366.
4. Levin KH, Copersino ML, Heishman SJ, Liu F, Kelly DL, et al. (2010) Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug and Alcohol Dependence 111: 120-127.
5. Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, et al. (2006) Cannabis withdrawal among non-treatment-seeking adult cannabis users. American Journal on Addictions 15: 8-14.
6. Cornelius JR, Chung T, Martin C, Wood DS, Clark DB, (2008) Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. Addictive Behaviors 33: 1500-1505.
7. Preuss UW, Watzke AB, Zimmermann J, Wong JW, Schmidt CO, (2010) Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients. Drug and Alcohol Dependence 106: 133-141.
8. Piontek D, Kraus L, Legleye S, Bühringer G, (2011) The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators. Addiction 106: 1137-1145.
9. Gorelick DA, Levin KH, Copersino ML, Heishman SJ, Liu F, et al. (2012) Diagnostic criteria for cannabis withdrawal syndrome. Drug and Alcohol Dependence 123: 141-147.
10. McBride O, Teesson M, Slade T, Baillie A, (2010) Theoretical and observed subtypes of DSM-IV alcohol- and cannabis-use disorders in the Australian population. J Stud Alcohol Drugs 71: 597-606.
11. Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ, (2011) The cannabis withdrawal scale development: patterns and predictors of cannabis withdrawal and distress. Drug and Alcohol Dependence 119: 123-129.
12. Hall W, Zador D, (1997) The alcohol withdrawal syndrome. The Lancet 349: 1897-1900.
13. Eyer F, Schuster T, Felgenhauer N, Pfab R, Strubel T, et al. (2011) Risk assessment of moderate to severe alcohol withdrawal-predictors for seizures and delirium tremens in the course of withdrawal. Alcohol and Alcoholism 46: 427-433.
14. Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB, (2003) Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. Journal of Abnormal Psychology 112: 14-27.
15. Farrell M, (1994) Opiate withdrawal. Addiction 89: 1471-1475.
16. Mattick RP, Hall W, (1996) Are detoxification programmes effective? The Lancet 347: 97-100.
17. Hasin DS, Keyes KM, Alderson D, S W, Aharonovich E, et al. (2008) Cannabis withdrawal in the United States: Results from NESARC. Journal of Clinical Psychiatry 69: 1354-1363.
18. Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, et al. (2008) Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology (Berl) 197: 157-168.
19. Agrawal A, Pergadia ML, Lynskey MT, (2008) Is There Evidence for Symptoms of Cannabis Withdrawal in the National Epidemiologic Survey of Alcohol and Related Conditions? American Journal on Addictions 17: 199-208.
20. Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z, (2008) Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. Journal of Substance Abuse Treatment 35: 362-368.
21. Cottler LB, Schuckit MA, Helzer JE, Crowley T, Woody G, et al. (1995) The DSM-IV field trial for substance use disorders: major results. Drug and Alcohol Dependence 38: 59-69 discussion 71-83.
22. Crowley TJ, Macdonald MJ, Whitmore EA, Mikulich SK, (1998) Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend 50: 27-37.
23. Vandrey R, Budney AJ, Kamon JL, Stanger C, (2005) Cannabis withdrawal in adolescent treatment seekers. Drug and Alcohol Dependence 78: 205-210.
24. Vandrey R, Budney A, Hughes J, Liguori A, (2008) A Within-Subject Comparison of Withdrawal Symptoms During Abstinence From Cannabis, Tobacco, and Both Substances. Drug and Alcohol Dependence 92: 48-54.
25. Gossop M, Darke S, Griffiths P, Hando J, Powis B, et al. (1995) The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90: 607-614.
26. Martin G, Copeland J, Gates P, Gilmour S, (2006) The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: Reliability, validity and diagnostic cut-off. Drug and Alcohol Dependence 83: 90-93.
27. Saunders JB, Aasland OG, Babor TF, de la Puente JR, Grant M, (1993) Development of the Alcohol Use Disorders Screening Test (AUDIT). WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction 88: 791-804.
28. Gossop M, Griffiths P, Powis B, Strang J, (1992) Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 87: 1527-1536.
29. Reinert DF, Allen JP, (2007) The alcohol use disorders identification test: an update of research findings. Alcoholism, Clinical and Experimental Research 31: 185-199.
30. Dybek I, Bischof G, Grothues J, Reinhardt S, Meyer C, et al. (2006) The reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German general practice population sample. Journal of Studies on Alcohol 67: 473-481.
31. Rubin A, Migneault JP, Marks L, Goldstein E, Ludena K, et al. (2006) Automated telephone screening for problem drinking. Journal of Studies on Alcohol 67: 454-457.
32. Ivis FJ, Adlaf EM, Rehm J, (2000) Incorporating the AUDIT into a general population telephone survey: a methodological experiment. Drug and Alcohol Dependence 60: 97-104.
33. Cook JM, Biyanova T, Thompson R, Coyne JC, (2007) Older primary care patients' willingness to consider discontinuation of chronic benzodiazepines. General Hospital Psychiatry 29: 396-401.
34. Gates P, Norberg M, Copeland J, Digiusto E, (2012) Randomised controlled trial of a novel cannabis use intervention delivered by telephone. Addiction In press.
35. First M, Spitzer R, Gibbon M, Williams J (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute.
36. Norberg MM, Mackenzie J, Copeland J, (2012) Quantifying cannabis use with the Timeline Followback approach: A psychometric evaluation. Drug and Alcohol Dependence 121: 247-252.
37. Sobell LC, Sobell MB (1995) Alcohol Timeline Followback Users' Manual Toronto, Canada Addiction Research Foundation.
38. Fu S, Lewis J, (2008) Novel automated extraction method for quantitative analysis of urinary 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid (THC-COOH). J Anal Toxicol 32: 292-297.
39. Musshoff F, Madea B, (2006) Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Therapeutic Drug Monitoring 28: 155-163.
40. Harrell FE (2001) Regression Modeling Strategies. New York: Springer.
41. Altman DG, Royston P, (2006) The cost of dichotomising continuous variables. BMJ 332: 1080.
42. Magee L, (1990) R2 measures based on Wald and likelihood ratio joint significance tests. American Statistician 44: 250-253.
43. Akaike H, (1974) A new look at the statistical model identification. Automatic Control, IEEE Transactions on 19: 716-723.
44. Zimmerman DW, Zumbo BD, (1993) Relative power of the Wilcoxon test, the Friedman Test, and Repeated-Measures ANOVA on Ranks. The Journal of Experimental Education 62: 75-86.
45. Copeland J, Swift W, Rees V, (2001) Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment 20: 45-52.
46. Hughes JR, Hatsukami D, (1986) Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 43: 289-294.
47. Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA, (2006) Caution regarding the use of pilot studies to guide power calculations for study proposals. Archives of General Psychiatry 63: 484-489.
48. Budney AJ, Hughes JR, Moore BA, Novy PL, (2001) Marijuana abstinence effects in marijuana smokers maintained in their home environment. Archives of General Psychiatry 58: 917-924.